Three Opportunities & Hurdles for AI in Healthcare

health-it-logo.png

March 21, 2018 - Increasingly, artificial intelligence (AI), machine learning (ML), and deep learning (DL) are gaining traction in financial markets, big data analytics, and consumer devices. But how will AI growth intersect with healthcare in the coming year? Interpreta’s Vice President, Medical Informatics and Genomics, Benjamin Yu, MD PhD, discusses the opportunities and challenges for healthcare executives in implementing AI in real-world healthcare environments.

Read the full article here: Becker’s Health IT & CIO Report

How Health Data From the Pharmacy & Your Genome Will Inform Care

genomeweb_logo.png

March 6, 2018 - Imagine if, in between picking up aspirin and finding a birthday card at the pharmacy, you could have basic biometrics data taken to automatically inform medication dosage and other care decisions by your doctor. It’s already starting to happen, and also includes analyzing your genome alongside that biometric and clinical data. A partnership between Interpreta and higi, with a network of 11,000 health self-screening stations at retail locations nationwide, is helping to support genomics-driven population health and closing gaps in care through collection and communication of patient vital signs and environmental data to healthcare professionals.

Read the full article here: GenomeWeb

Why Continuous Interpretation of Clinical and Genomics Data Is the Future of Healthcare

600x400.png

February 27, 2018 - Now that the cost for sequencing an entire genome has fallen under $1000, it’s likely that EHRs will soon need to interpret whole or partial genomes. EHRs and CDS systems will need to be smart about analyzing relevant genetic variant information when there is a change in the patient’s medical history or if new genetic guidance is issued. Interpreta Vice President for Quality and Risk Analytics Matt Yuill M.D. outlines why genomic profiles and numerous other data sources now require frequent interpretation to extract their clinical value in a February 2018 Healthcare Analytics News article.

Read the full article here

How Genomics Is Set To Revolutionize Decision-Making

Lossdfgo.jpeg

February 9, 2018 - Single gene testing has already been influencing clinical decision-making, such as in assessing breast cancer risk and how long a patient will need to stay on medication. But the whole genome will soon become an integral part of practitioners’ decision-making processes. How will genomics better inform providers on everything from risk and progression of disease, to individual response to treatment? Matt Yuill, M.D., Vice President, Quality and Risk Analytics at Interpreta, addresses this, and how barriers to leveraging genomics are being removed, in his latest article in Health IT Outcomes.

Read the full article here

Interpreta Recognized as a Top 10 Genomics Solution Provider by Pharma Tech Outlook

interpreta_cert_pharma_tech.png

January 3, 2018 – Interpreta was named a Top 10 Genomics Solution Provider in 2017 by Pharma Tech Outlook Magazine and is featured in this month’s issue. Pharma Tech Outlook actively tracked 300 nominations, reviewed reports, industry news, social media and surveys with potential buyers, as well as conducted independent research, to arrive at the top 10. Read more about Interpreta being recognized for interpreting genomic, clinical, and FDA guidelines to tailor care for improved clinical outcomes.

Read the full article here

Interpreta Featured in Group Practice Journal - "Massive Genomic Data Needs Predicted"

Interpreta Featured in Group Practice Journal - "Massive Genomic Data Needs Predicted"

November 3, 2017 - It’s predicted that the computing power required to use genomic data will soon be equal to – or more demanding than – the three other major generators of big data: astronomy, YouTube, and Twitter. With over 49,000 genetic tests for 9,000+ human conditions, the use of genomic data to inform and improve patient care decisions continues to grow. But to be effective, the data needs to be continuously interpreted alongside changes in clinical context and other factors.

Read More

Interpreta Featured in ClinicalOMICs – “Retail Engagement: Interpreta and higi eye healthcare 'roadmaps' using patient data collected at grocers, pharmacies"

October 6, 2017 - The Sept/Oct issue of ClinicalOMICs talks about the Interpreta and higi partnership which, for the first time, integrates biometric data from higi health stations with clinical, claims, and genomic data from Interpreta to enable physicians and insurers to create personalized-care plans for patients. Read the full article on how the partnership is making direct-to-consumer (DTC) healthcare possible and empowering patients.

Read the full article here

Interpreta has been recognized as one of the “10 Most Promising Healthcare Analytics Solution Providers” by Healthcare Tech Outlook Magazine

August 11, 2017 - Interpreta is featured as the cover story for the publication’s August issue, with company founders on the cover. Healthcare Tech Outlook recognizes Interpreta as “pioneering the future of clinical interpretation” through its ability to enable precision medicine.

Read the full article here

Interpreta Executives Address How Genomic Medicine Will Enhance Clinical Practice in Becker's Hospital Review

Interpreta Executives Address How Genomic Medicine Will Enhance Clinical Practice in Becker's Hospital Review

April 3, 2017 - What is genomic medicine? And how is it primed to not only improve care, but make it more cost-effective? Interpreta’s Jaime Barea MD, Director of Medical Genetics; Tim Sayed MD, MBA, Vice President, Physician Engagement; and Benjamin Yu, MD PhD, Vice President, Medical Informatics and Genomics at Interpreta recently published an article on this topic in Becker’s Hospital Review.

Read More

Interpreta VP Addresses Precision Medicine Challenges and Opportunities in For the Record Magazine

Interpreta VP Addresses Precision Medicine Challenges and Opportunities in For the Record Magazine

August 19, 2016 - Interpreta's Vice President of Physician Engagement, Tim Sayed, M.D., MBA, writes in For The Record magazine about the implications of precision medicine in practice and the role technology plays in implementing true precision medicine.

Read the article at Precision Medicine: It's Complicated

Read More